help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2006-1440
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maile, L. A.
Right arrow Articles by Clemmons, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maile, L. A.
Right arrow Articles by Clemmons, D. R.
Endocrinology Vol. 148, No. 5 2435-2443
Copyright © 2007 by The Endocrine Society

Hyperglycemia Alters the Responsiveness of Smooth Muscle Cells to Insulin-Like Growth Factor-I

Laura A. Maile, Byron E. Capps, Yan Ling, Gang Xi and David R. Clemmons

Division of Endocrinology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7170

Address all correspondence and requests for reprints to: Laura A. Maile, Ph.D., 5029 Burnett Womack, CB 7170, University of North Carolina, Chapel Hill, North Carolina 27599-7170. E-mail: laura_maile{at}med.unc.edu.

IGF-I stimulation of smooth muscle cell (SMC) migration and proliferation requires {alpha}Vß3 ligand occupancy. We hypothesized that changes in the levels of extracellular matrix proteins induced by alterations in glucose concentrations may regulate the ability of SMCs to respond to IGF-I. IGF-I stimulated migration and proliferation of SMCs that had been maintained in 25 mM glucose containing media, but it had no stimulatory effect when tested using SMCs that had been grown in 5 mM glucose. IGF-I stimulated an increase in Shc phosphorylation and enhanced activation of the MAPK pathway in SMCs grown in 25 mM glucose, whereas in cells maintained in 5 mM glucose, IGF-I had no effect on Shc phosphorylation, and the MAPK response to IGF-I was markedly reduced. In cells grown in 25 mM glucose, the levels of {alpha}Vß3 ligands, e.g. osteopontin, vitronectin, and thrombospondin, were all significantly increased, compared with cells grown in 5 mM glucose. The addition of these {alpha}Vß3 ligands to SMCs grown in 5 mM glucose was sufficient to permit IGF-I-stimulated Shc phosphorylation and downstream signaling. Because we have shown previously that {alpha}Vß3 ligand occupancy is required for IGF-I-stimulated Shc phosphorylation and stimulation of SMC growth, our data are consistent with a model in which 25 mM glucose stimulates increases in the concentrations of these extracellular matrix proteins, thus enhancing {alpha}Vß3 ligand occupancy, which leads to increased Shc phosphorylation and enhanced cell migration and proliferation in response to IGF-I.




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
X. Shen, G. Xi, Y. Radhakrishnan, and D. R. Clemmons
Identification of Novel SHPS-1-associated Proteins and Their Roles in Regulation of Insulin-like Growth Factor-dependent Responses in Vascular Smooth Muscle Cells
Mol. Cell. Proteomics, July 1, 2009; 8(7): 1539 - 1551.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. B. Allen, B. E. Capps, E. C. Miller, D. R. Clemmons, and L. A. Maile
Glucose-Oxidized Low-Density Lipoproteins Enhance Insulin-Like Growth Factor I-Stimulated Smooth Muscle Cell Proliferation by Inhibiting Integrin-Associated Protein Cleavage
Endocrinology, March 1, 2009; 150(3): 1321 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A. Colao, C. Di Somma, T. Cascella, R. Pivonello, G. Vitale, L. F S Grasso, G. Lombardi, and S. Savastano
Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects
Eur. J. Endocrinol., October 1, 2008; 159(4): 389 - 397.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. A. Maile, B. E. Capps, E. C. Miller, A. W. Aday, and D. R. Clemmons
Integrin-Associated Protein Association With Src Homology 2 Domain Containing Tyrosine Phosphatase Substrate 1 Regulates IGF-I Signaling In Vivo
Diabetes, October 1, 2008; 57(10): 2637 - 2643.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. Xi, X. Shen, and D. R. Clemmons
p66shc Negatively Regulates Insulin-Like Growth Factor I Signal Transduction via Inhibition of p52shc Binding to Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 Leading to Impaired Growth Factor Receptor-Bound Protein-2 Membrane Recruitment
Mol. Endocrinol., September 1, 2008; 22(9): 2162 - 2175.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Radhakrishnan, L. A. Maile, Y. Ling, L. M. Graves, and D. R. Clemmons
Insulin-like Growth Factor-I Stimulates Shc-dependent Phosphatidylinositol 3-Kinase Activation via Grb2-associated p85 in Vascular Smooth Muscle Cells
J. Biol. Chem., June 13, 2008; 283(24): 16320 - 16331.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. A. Maile, B. E. Capps, E. C. Miller, L. B. Allen, U. Veluvolu, A. W. Aday, and D. R. Clemmons
Glucose Regulation of Integrin-Associated Protein Cleavage Controls the Response of Vascular Smooth Muscle Cells to Insulin-Like Growth Factor-I
Mol. Endocrinol., May 1, 2008; 22(5): 1226 - 1237.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society